Trelstar

Prostate Cancer Drugs Aren’t Tied to Heart Attacks, Study Says
Bloomberg Businessweek
Wed, 12/7/11 - 11:05 am
prostate cancer
AstraZeneca
Watson
Lupron
Abbott Laboratories
Vantas
Trelstar
Zoladex
Endo
FDA Calls for New Warnings on Some Prostate Cancer Drugs
Yahoo/Health Day
Thu, 10/21/10 - 11:12 am
FDA
prostate cancer
Eligard
Lupron
Synarel
Trelstar
Vantas
Viadur
Zoladex
GnRH antagonists